Utilization of CDX2 Expression in Diagnosing Pancreatic Ductal Adenocarcinoma and Predicting Prognosis

Reevaluation and Identification of the Best Immunohistochemical Panel (pVHL, Maspin, S100P, IMP-3) for Ductal Adenocarcinoma of the Pancreas

(2012) Haiyan Liu et al.   ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE

Up-Regulation of Cadherin 17 and Down-Regulation of Homeodomain Protein CDX2 Correlate With Tumor Progression and Unfavorable Prognosis in Epithelial Ovarian Cancer

(2012) Li-Ping Huang et al.   INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER

CDX2 is an amplified lineage-survival oncogene in colorectal cancer

(2012) K. Salari et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Pancreatic cancer

(2011) Audrey Vincent et al.   LANCET

Expression of CDX2 and Hepatocyte Antigen in Benign and Malignant Lesions of Gallbladder and Its Correlation with Histopathologic Type and Clinical Outcome

(2011) Qing-Long Li et al.   PATHOLOGY & ONCOLOGY RESEARCH

The homeobox gene CDX2 is aberrantly expressed and associated with an inferior prognosis in patients with acute lymphoblastic leukemia

(2009) S Thoene et al.   LEUKEMIA

Homeobox Gene CDX2 Inhibits Human Pancreatic Cancer Cell Proliferation by Down-Regulating Cyclin D1 Transcriptional Activity

(2008) Kenji Takahashi et al.   PANCREAS